Depotestogen Interactions
There are 401 drugs known to interact with Depotestogen (estradiol / testosterone), along with 28 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 42 are major, 339 are moderate, and 20 are minor.
- View all 401 medications that may interact with Depotestogen
- View Depotestogen alcohol/food interactions (4)
- View Depotestogen disease interactions (28)
Most frequently checked interactions
View interaction reports for Depotestogen (estradiol / testosterone) and the medicines listed below.
- acetaminophen
- Actos (pioglitazone)
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Aldactazide (hydrochlorothiazide / spironolactone)
- alendronate
- alprazolam
- amlodipine
- Aspirin Low Strength (aspirin)
- atorvastatin
- B Complex 100 (multivitamin)
- baclofen
- bumetanide
- Bumex (bumetanide)
- Cardura (doxazosin)
- Centrum Silver (multivitamin with minerals)
- clopidogrel
- Combivent Respimat (albuterol / ipratropium)
- Cozaar (losartan)
- Diltiazem Hydrochloride XT (diltiazem)
- docusate
- Dyazide (hydrochlorothiazide / triamterene)
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- Ferrex-150 (iron polysaccharide)
- Flonase (fluticasone nasal)
- omeprazole
- Requip (ropinirole)
- Synthroid (levothyroxine)
- Vitamin D3 (cholecalciferol)
Depotestogen alcohol/food interactions
There are 4 alcohol/food interactions with Depotestogen (estradiol / testosterone).
Depotestogen disease interactions
There are 28 disease interactions with Depotestogen (estradiol / testosterone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- renal/liver disease
- diabetes
- hypercalcemia
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- thyroid function tests
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.